Journal: PLoS Pathogens
Article Title: Human Cytomegalovirus Induces TGF-β1 Activation in Renal Tubular Epithelial Cells after Epithelial-to-Mesenchymal Transition
doi: 10.1371/journal.ppat.1001170
Figure Lengend Snippet: (A) HK-2 cells were infected with HCMV strain TR at MOI of 1 and incubated with inhibitors, GM6001, aprotinin, anti-thrombospondin 1(α-TSP), or anti-α v β 6 integrin (α- αvβ6), prior to stimulation with raTGF-β1 at 15 ng/ml (0.6 nM), washed, and TGF-β1 luciferase bioassay performed for active TGF-β1. Results were compared to those from uninfected, unstimulated HK-2 cells (HCMV TR-/raTGF-β1-) as well as HK-2 cells infected with HCMV and stimulated with raTGF-β1 (HCMV TR+/raTGF-β1+). Both GM6001 and aprotinin significantly inhibited active TGF-β1 production. Legend: (**) p<0.05; (***) p<0.01. (B) HK-2 cells were untreated, or were infected with HCMV at MOI of 1 and/or treated with raTGF-β1. Cell lysates were subjected to gelatin zymography (zymogram) and western blotting using anti-MMP-2 (anti-MMP-2). Pro- and active MMP-2 could be detected only in HCMV infected, raTGF-β1 stimulated cells. (C, D) HK-2 cells were treated as in (A), but lysates were either subjected directly to western blotting for TIMP-2, MT3-MMP, MT1-MMP, or actin (C) or incubated with mouse anti-MMP-2 followed by protein A-agarose, and immunoprecipitated proteins subjected to western blotting using rabbit anti-MMP-2, anti-TIMP-2, anti-MT3-MMP, and anti-MT1-MMP. TIMP-2 and MT3-MMP immunoprecipitated with MMP-2 only in HCMV infected, raTGF-β1 stimulated cells. (E) HK-2 cells were transfected with MMP-2 shRNA plasmid (MMP-2), or a control scrambled plasmid (Ctrl). Cells were infected with HCMV strain TR at MOI of 1 and/or stimulated with raTGF-β1 at 15 ng/ml. Supernatants were subjected to luciferase assay for active TGF-β1 (top panel). A portion of the cell pellets were subjected to western blotting for MMP-2, GFP, and actin (middle panel). RNA was extracted from the remainder of the cell pellets and RT-PCR performed for MMP-2 (bottom panel), with results depicted as fold change between raTGF-β1 exposed and non-exposed transfections. These assays showed that MMP-2 shRNA transfection reduced active TGF-β1, MMP-2 protein and mRNA; the control transfections stimulated with raTGF-β1 did induce active TGF-β1, MMP-2 protein and mRNA.
Article Snippet: The following reagents were purchased from commercial vendors: recombinant human active TGF-β1 (raTGF-β1), Quantikine human TGF-β1 ELISA, TGF-β1 blocking antibody (clone 9016) (R&D Systems, Minneapolis MN); luciferase assay reagent, β-galactosidase assay kit (Promega Corp., Madison WI); RNeasy kit (Qiagen, Valencia CA); RT 2 First Strand Kit, SuperArray Human Extracellular Matrix PCR Array, human MMP-2 shRNA kit (SABiosciences, Frederick MD), Cells-to-CT kit (Applied Biosystems, Foster City CA); GM6001, rabbit anti-MMP-2 antibody (AB19167); rabbit anti- MT3-MMP antibody (AB853), mouse anti-α v β 6 blocking antibody (MAB2077Z) (Millipore, Billerica MA); pEF1/myc-his/lacZ plasmid, anti-GFP antibody, AlexaFluor conjugated phalloidin and secondary antibodies, and SuperScript III kit (Invitrogen); Cytogam (CSL Behring, King of Prussia PA); Nucleofector device and transfection kit V (Amaxa, Gaithersburg MD).
Techniques: Infection, Incubation, Luciferase, Zymography, Western Blot, Immunoprecipitation, Transfection, shRNA, Plasmid Preparation, Reverse Transcription Polymerase Chain Reaction